Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?

被引:0
|
作者
Rahman, Manar A. Abdel [1 ]
Arram, Eman O. [2 ]
Hamid, Amr Abdel [2 ]
机构
[1] Mansoura Univ, Fac Med, Dept Pathol, Mansoura, Egypt
[2] Mansoura Univ, Fac Med, Dept Thorac Med, Mansoura, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2019年 / 68卷 / 04期
关键词
immunohistochemistry; lung cancer; prognosis; EXPRESSION; CARCINOMA; BCL-2; KI-67; TTF-1; EGFR; P53;
D O I
10.4103/ejcdt.ejcdt_94_18
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Aim We aim to assess prognostic significance of immunohistochemistry represented in Napsin A and CK 5/6 in NSCLC, Moreover we aim to correlate histologic patterns of adenocarcinoma with Napsin A expression and identify its prognostic significance. Patients and methods The study was conducted on 130 cases diagnosed pathologically as NSCLC, and then we used Napsin A and CK 5/6 for subtyping them into actual histologic types (108 cases were diagnosed as adenocarcinoma and 22 cases as squamous cell carcinoma, we correlated expression levels of Napsin A and CK 5/6 to different clinicopathological variants. Results Napsin A score 2 was high in age more than or equal 60 years while Napsin A score 3 was high in age less than 50 years also Napsin A score 3 was high in cases with lymph node metastasis, while CK 5/6 was associated with cases without distant metastasis. Conclusion Both Napsin A and CK 5/6 could be used as prognostic and diagnostic markers in NSCLC.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 50 条
  • [21] Prognostic factors in non-small cell lung cancer surgery
    Birim, Ö
    Kappetein, AP
    van Klaveren, R
    Bogers, AMC
    EJSO, 2006, 32 (01): : 12 - 23
  • [22] A Meta Analysis on Prognostic Value of Patients with Non-Small Cell Lung Cancer
    Rui, Jiang
    Li Yingping
    Gu, Lijun
    Wang, Zhiyan
    Zuo, Jing
    Zha, Lin
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2018, 8 (09) : 1875 - 1880
  • [23] LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers
    Fu, Jiang
    Yu, Li
    Yan, Hang
    Tang, Shengjie
    Wang, Zixu
    Dai, Tingting
    Chen, Haoyu
    Zhang, Song
    Hu, Haiyang
    Liu, Tao
    Tang, Shoujun
    He, Rong
    Zhou, Haining
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [24] ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer
    Zhang, Binbin
    Xu, Aiqun
    Wu, Dong
    Xia, Wanli
    Li, Pulin
    Wang, Enze
    Han, Rui
    Sun, Peng
    Zhou, Sijing
    Wang, Ran
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 6557 - 6574
  • [25] Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer
    Jin, Meng-Meng
    Ye, Yuan-Zi
    Qian, Zhen-Dong
    Zhang, Yan-Bei
    ONCOLOGY LETTERS, 2015, 10 (05) : 3252 - 3260
  • [26] The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) : 735 - 742
  • [27] Analysis of the prognostic impact of nestin expression in non-small cell lung cancer
    Skarda, Jozef
    Kolar, Zdenek
    Janikova, Maria
    Radova, Lenka
    Kolek, Vitezslav
    Fridman, Edi
    Kopolovic, Juri
    BIOMEDICAL PAPERS-OLOMOUC, 2012, 156 (02): : 135 - 142
  • [28] Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
    Mino-Kenudson, Mari
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (05) : 570 - 587
  • [29] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Wan, Yanhui
    Qian, Youhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [30] p27kiP1 Expression in Non-small Cell Lung Cancer Is not an Independent Prognostic Factor
    Sion-Vardy, Netta
    Freedman, Janna
    Lazarov, Irena
    Bolotin, Arkady
    Ariad, Samuel
    ANTICANCER RESEARCH, 2010, 30 (09) : 3699 - 3704